Return to:
Diabetes ArticlesOr:
Recent Diabetes Articleshttp://www.cnbc.com/id/21364429CNBC - CNBC’s Mike Huckman said Pfizer’s “bombshell” announcement that it will cease selling its once-promising inhalable insulin product Exubera took down a number of stocks in the diabetes care industry, including Lilly, Alkermes (ALKS) , MannKind ...
Article Finder:
October 18, 2007 04:31:00 PM
